Key Highlights

• Q1 2026 Net Income Surges to \$15.7 Million — More than double the \$7.7 million reported in Q1 2025.
• Gross Profit Jumps to \$19.2 Million — Reflecting a robust gross margin of 42%.
• Adjusted EBITDA Rises to \$5.1 Million — Up \$2.8 million from Q1 2025, signaling improved core operating performance.
• Cronos is Flush with Cash — Cash and cash equivalents total \$821.9 million at quarter-end, with zero short-term investments.
• Renewed \$50 Million Share Repurchase Program — Unanimously approved by the Board on May 8, 2026, to succeed the existing program.
• Active Financial Management — Repurchased \$16.7 million in stock during the quarter.
• Solid Equity Base — Total shareholders’ equity stands at \$1.12 billion.

Detailed Financial Performance

Net Revenues and Gross Profit: Cronos Group reported net income of \$15.7 million for the quarter ended March 31, 2026, a significant increase from \$7.7 million in the same quarter of 2025. The company’s gross profit stood at \$19.2 million, translating into a robust gross margin of 42%, highlighting strong operational efficiency in the period.

Adjusted EBITDA: Adjusted EBITDA, a key measure of core operating performance, was \$5.1 million, up by \$2.8 million compared to Q1 2025. Management attributed this improvement primarily to higher gross profit, partially offset by increased operating expenses, particularly in sales and marketing, general and administrative, and research and development costs.

Cash Position: As of March 31, 2026, Cronos Group is in an exceptionally strong liquidity position, with \$821.9 million in cash and cash equivalents and no short-term investments. This provides substantial flexibility for future investments, acquisitions, or shareholder returns.

Shareholders’ Equity: Total equity attributable to Cronos Group shareholders is \$1.07 billion, with an additional \$50.2 million in non-controlling interests, bringing total shareholders’ equity to \$1.12 billion.

Share Repurchase Program — Key Price-Sensitive Development

On May 8, 2026, the Board of Directors unanimously authorized a new share repurchase program of up to \$50 million. This new program is intended to succeed the Company’s existing share repurchase program as it concludes. The renewal and expansion of the buyback plan reflect the Board’s confidence in Cronos’ financial health and long-term prospects.

During Q1 2026, Cronos repurchased \$16.7 million of its common stock, providing direct support to the share price and offering a clear signal of management’s belief that the shares are undervalued at current levels. Furthermore, the company paid \$1.54 million in withholding taxes on share-based awards during the quarter.

This ongoing and expanded buyback activity is highly price-sensitive and could positively impact the share price by reducing the float and underscoring management’s bullish outlook.

Other Noteworthy Items

• Interest Income: The company generated \$8.85 million in net interest income during the quarter, reflecting effective cash management and providing a cushion against operational risks.
• Operating Expenses: Sales and marketing expenses were \$5.6 million (up from \$4.6 million in Q1 2025), and share-based compensation was \$1.31 million (down from \$2.09 million a year earlier), indicating ongoing investments in growth and talent retention.
• Restructuring Costs: The company incurred \$0.48 million in restructuring costs, down slightly from \$0.56 million in the prior year period.
• Foreign Exchange Impact: There was a significant foreign exchange loss on translation of \$17.9 million, which negatively impacted comprehensive income.
• Comprehensive Income: Despite strong net income, the company reported a comprehensive loss of \$2.23 million for Q1 2026, primarily due to foreign currency translation adjustments.
• Non-GAAP Measures: Cronos continues to provide Adjusted EBITDA and other non-GAAP metrics to aid investors in understanding core operating performance, but cautions that these measures should not be considered superior to U.S. GAAP results.

Outlook and Forward-Looking Statements

Management emphasized that Q1 2026 results demonstrate strong operational progress and robust financial health, supporting the company’s ongoing investments in innovation and market expansion. However, Cronos also highlighted several forward-looking risks, including regulatory uncertainties, potential impairment losses, macroeconomic conditions, and the impact of ongoing geopolitical events such as the Russia-Ukraine conflict.

Investors should monitor the company’s ongoing compliance with settlement agreements with U.S. and Canadian securities regulators, as well as the potential impact of losing the ability to rely on private offering exemptions under U.S. securities law.

Conclusion

Investor Takeaway: Cronos Group delivered an outstanding Q1 2026, with net income more than doubling year-on-year, strong cash generation, and a robust equity base. The new \$50 million share repurchase authorization is a significant, price-sensitive development that underscores management’s confidence and may provide support for the stock price. Investors should, however, remain aware of foreign currency risks and ongoing regulatory matters.